AURORA, CO / ACCESS Newswire / September 22, 2026 / Rezera Inc. (the "Company"), a clinical-stage biotechnology company developing a...
Collaboration will integrate Sanguina's AI-enabled patented fingernail analysis technology into My Pediatric Doctor and My Adult Doctor, with future applications...
Late-breaking study presented at HRX 2026 met primary feasibility endpoint in 100% of patientsMajority of patients had minimal or no...
Former Chief Executive Officer of PA Consulting brings three decades of global professional services and life sciences leadership experienceAppointment broadens...
Clinical Milestone Expands Development of Paxalisib Beyond Oncology and Triggers $2 Million Payment to KaziaSYDNEY, Sept. 22, 2026 /PRNewswire/ --...
Dr. Zahoorudin, MBBS, M.D., a board-certified diplomate of the American Academy of Stem Cell Physicians, (AASCP) USA, credits Stemtech's stem...
Nasdaq confirms compliance with continued listing standard and closes the matter SAN ANTONIO, TX / ACCESS Newswire / September 22,...
A new Canadian patent, "Psychoactive Alkaloid Extraction and Composition with Controlled Dephosphorylation," has been issued by the Canadian Intellectual Property...
WELL Research is the clinical research brand of WELL Health Technologies. WELL Research offers the unique combination of full-service contract...
New agreement brings innovative diagnostic, shock wave therapy, and remote monitoring solutions to more than 2,000 member practices across the...
Filament has shipped PEX010 to Bruyère Health Research Institute for its Phase 3 placebo-controlled trial, which follows a published Phase...
The paper introduces three interconnected resources for the global scientific community:LongevityBench, the first open benchmark designed to rigorously evaluate AI...
Chemists can now estimate which compounds will have the best human dose before making them in the labNEW YORK, Sept....
New agent marks major expansion of Condor's AI platform, enables biopharma R&D teams to ask complex questions about their clinical...
HENDERSON, Nev., Sept. 17, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) (XASE: VNRX) (together with affiliates "Volition"), a multi-national epigenetics...
Vancouver, British Columbia--(Newsfile Corp. - September 17, 2026) - BetterLife Pharma Inc. (CSE: BETR) ("BetterLife" or the "Company"), a biotechnology...
Filament will supply PEX010 1 mg and 5 mg capsules, with matching placebo, for a study of low and medium...
Opinion: Current lung cancer screening policy leaves gaps around air pollution, exposure, and genetics. Two new trials in India are...
In this free webinar, learn how sponsors can evaluate when emerging science in oncology is ready for clinical development and...
SEATTLE, Sept. 15, 2026 /PRNewswire/ -- ModernVivo, a company dedicated to helping preclinical R&D teams design their in vivo studies in...